SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001424884-16-000257
Filing Date
2016-11-14
Accepted
2016-11-14 12:43:32
Documents
36
Period of Report
2016-09-30

Document Format Files

Seq Description Document Type Size
1 COMPANY FORM 10-Q FOR PERIOD ENDING 9-30-2016.. form10q.htm 10-Q 231518
2 ex31-1.htm EX-31.1 12620
3 ex31-2.htm EX-31.2 12439
4 ex32-1.htm EX-32.1 3286
5 ex32-2.htm EX-32.2 3168
  Complete submission text file 0001424884-16-000257.txt   859398

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT ctbo-20160930.xml EX-101.INS 64373
7 XBRL TAXONOMY EXTENSION SCHEMA ctbo-20160930.xsd EX-101.SCH 12189
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE ctbo-20160930_cal.xml EX-101.CAL 9369
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE ctbo-20160930_def.xml EX-101.DEF 24708
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE ctbo-20160930_lab.xml EX-101.LAB 71082
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE ctbo-20160930_pre.xml EX-101.PRE 65258
Mailing Address 2225 EAST BAYSHORE ROAD PALO ALTO CA 94303
Business Address 2225 EAST BAYSHORE ROAD PALO ALTO CA 94303 844-200-2826
Cantabio Pharmaceuticals Inc. (Filer) CIK: 0001550518 (see all company filings)

IRS No.: 990373067 | State of Incorp.: DE | Fiscal Year End: 0331
Type: 10-Q | Act: 34 | File No.: 000-54906 | Film No.: 161992858
SIC: 2834 Pharmaceutical Preparations